| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active-specific immunization against melanoma: Is the problem at the receiving end?
|
Monsurrò, Vladia
|
|
2003
|
104-105 |
6 |
p. 473-480
8 p.
|
article
|
| 2 |
Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine
|
Hsueh, Eddy C
|
|
2003
|
104-105 |
6 |
p. 401-407
7 p.
|
article
|
| 3 |
Antigens in chronic lymphocytic leukemia—Implications for cell origin and leukemogenesis
|
Rosén, Anders
|
|
2010
|
104-105 |
6 |
p. 400-409
10 p.
|
article
|
| 4 |
Anti-idiotypic monoclonal antibody cancer vaccines
|
Chapman, Paul B.
|
|
1995
|
104-105 |
6 |
p. 367-374
8 p.
|
article
|
| 5 |
Augmenting the immunogenicity of carbohydrate tumor antigens
|
Livingston, Philip O.
|
|
1995
|
104-105 |
6 |
p. 357-366
10 p.
|
article
|
| 6 |
Author index 1995
|
|
|
1995
|
104-105 |
6 |
p. I-
1 p.
|
article
|
| 7 |
Author Index and Keyword Index
|
|
|
2000
|
104-105 |
6 |
p. ix-xii
nvt p.
|
article
|
| 8 |
Autophagy in cancer: Having your cake and eating it
|
Hoare, Matthew
|
|
2011
|
104-105 |
6 |
p. 397-404
8 p.
|
article
|
| 9 |
Burkitt lymphoma
|
Klein, Eva
|
|
2009
|
104-105 |
6 |
p. 345-346
2 p.
|
article
|
| 10 |
Burkitt lymphoma—A stalking horse for cancer research?
|
Klein, George
|
|
2009
|
104-105 |
6 |
p. 347-350
4 p.
|
article
|
| 11 |
Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology
|
Rowe, Martin
|
|
2009
|
104-105 |
6 |
p. 377-388
12 p.
|
article
|
| 12 |
Cancer, aging and the optimal tissue design
|
Komarova, Natalia L.
|
|
2005
|
104-105 |
6 |
p. 494-505
12 p.
|
article
|
| 13 |
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells
|
Deaglio, Silvia
|
|
2010
|
104-105 |
6 |
p. 416-423
8 p.
|
article
|
| 14 |
CD8+ T cell immunity to Epstein-Barr virus and Kaposi’s sarcoma-associated herpes virus
|
Hislop, Andrew D.
|
|
2008
|
104-105 |
6 |
p. 416-422
7 p.
|
article
|
| 15 |
Cell transformation induced by Epstein–Barr virus—living dangerously
|
Rowe, Martin
|
|
2001
|
104-105 |
6 |
p. 403-405
3 p.
|
article
|
| 16 |
Cellular senescence—A barrier against tumor development?
|
Larsson, Lars-Gunnar
|
|
2011
|
104-105 |
6 |
p. 347-348
2 p.
|
article
|
| 17 |
Cellular senescence: A link between cancer and age-related degenerative disease?
|
Campisi, Judith
|
|
2011
|
104-105 |
6 |
p. 354-359
6 p.
|
article
|
| 18 |
Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting
|
Burger, Jan A.
|
|
2010
|
104-105 |
6 |
p. 424-430
7 p.
|
article
|
| 19 |
Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma
|
Allen Chan, K.C
|
|
2002
|
104-105 |
6 |
p. 489-496
8 p.
|
article
|
| 20 |
Clinical and biological significance of HLA-G expression in ovarian cancer
|
Sheu, Jim Jinn-Chyuan
|
|
2007
|
104-105 |
6 |
p. 436-443
8 p.
|
article
|
| 21 |
CLL-like monoclonal B-cell lymphocytosis: Are we all bound to have it?
|
Scarfò, Lydia
|
|
2010
|
104-105 |
6 |
p. 384-390
7 p.
|
article
|
| 22 |
Commentary
|
Klein, George
|
|
2002
|
104-105 |
6 |
p. 415-418
4 p.
|
article
|
| 23 |
Contents and index of volume 7, 1996
|
|
|
1996
|
104-105 |
6 |
p. i-xv
nvt p.
|
article
|
| 24 |
Contents of Volume 10
|
|
|
2000
|
104-105 |
6 |
p. i-viii
nvt p.
|
article
|
| 25 |
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus
|
Delecluse, Henri-Jacques
|
|
2008
|
104-105 |
6 |
p. 409-415
7 p.
|
article
|
| 26 |
Control of papillomavirus DNA replication and transcription
|
Desaintes, Christian
|
|
1996
|
104-105 |
6 |
p. 339-347
9 p.
|
article
|
| 27 |
Current criteria to establish human carcinogens
|
Cogliano, Vincent James
|
|
2004
|
104-105 |
6 |
p. 407-412
6 p.
|
article
|
| 28 |
Definition of tumor antigens suitable for vaccine construction
|
Lewis, Jonathan J.
|
|
1995
|
104-105 |
6 |
p. 321-327
7 p.
|
article
|
| 29 |
Dendritic cells as vectors for immunotherapy of cancer
|
Paczesny, Sophie
|
|
2003
|
104-105 |
6 |
p. 439-447
9 p.
|
article
|
| 30 |
Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration
|
Andersen, Mads Hald
|
|
2003
|
104-105 |
6 |
p. 449-459
11 p.
|
article
|
| 31 |
Dynamics of colorectal cancer
|
Michor, Franziska
|
|
2005
|
104-105 |
6 |
p. 484-493
10 p.
|
article
|
| 32 |
EBNA2 and Notch signalling in Epstein–Barr virus mediated immortalization of B lymphocytes
|
Zimber-Strobl, Ursula
|
|
2001
|
104-105 |
6 |
p. 423-434
12 p.
|
article
|
| 33 |
EBV and genomic instability—A new look at the role of the virus in the pathogenesis of Burkitt's lymphoma
|
Gruhne, Bettina
|
|
2009
|
104-105 |
6 |
p. 394-400
7 p.
|
article
|
| 34 |
Editorial Board
|
|
|
2008
|
104-105 |
6 |
p. CO2-
1 p.
|
article
|
| 35 |
Editorial Board
|
|
|
2007
|
104-105 |
6 |
p. CO2-
1 p.
|
article
|
| 36 |
Editorial Board
|
|
|
2009
|
104-105 |
6 |
p. CO2-
1 p.
|
article
|
| 37 |
Editorial Board
|
|
|
2010
|
104-105 |
6 |
p. CO2-
1 p.
|
article
|
| 38 |
Editorial Board
|
|
|
2011
|
104-105 |
6 |
p. CO2-
1 p.
|
article
|
| 39 |
Emergence and prevention of resistance against small molecule inhibitors
|
Wodarz, Dominik
|
|
2005
|
104-105 |
6 |
p. 506-514
9 p.
|
article
|
| 40 |
Emerging concepts in tumor progression and therapy
|
Classon, Marie
|
|
2000
|
104-105 |
6 |
p. 393-397
5 p.
|
article
|
| 41 |
Endemic Burkitt's lymphoma as a polymicrobial disease
|
Chene, Arnaud
|
|
2009
|
104-105 |
6 |
p. 411-420
10 p.
|
article
|
| 42 |
Environmental and chemical carcinogenesis
|
Wogan, Gerald N.
|
|
2004
|
104-105 |
6 |
p. 473-486
14 p.
|
article
|
| 43 |
Epidemiology of nasopharyngeal carcinoma
|
Yu, Mimi C.
|
|
2002
|
104-105 |
6 |
p. 421-429
9 p.
|
article
|
| 44 |
Epigenetic alterations associated with cellular senescence: A barrier against tumorigenesis or a red carpet for cancer?
|
Decottignies, Anabelle
|
|
2011
|
104-105 |
6 |
p. 360-366
7 p.
|
article
|
| 45 |
Epitope selection and development of peptide based vaccines to treat cancer
|
Celis, Esteban
|
|
1995
|
104-105 |
6 |
p. 329-336
8 p.
|
article
|
| 46 |
Epstein–Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue
|
Bornkamm, Georg W.
|
|
2009
|
104-105 |
6 |
p. 351-365
15 p.
|
article
|
| 47 |
Epstein–Barr virus complementary strand transcripts (CSTs / BARTs) and cancer
|
Smith, Paul
|
|
2001
|
104-105 |
6 |
p. 469-476
8 p.
|
article
|
| 48 |
Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products
|
Ressing, Maaike E.
|
|
2008
|
104-105 |
6 |
p. 397-408
12 p.
|
article
|
| 49 |
Epstein–Barr virus in the pathogenesis of NPC
|
Raab-Traub, Nancy
|
|
2002
|
104-105 |
6 |
p. 431-441
11 p.
|
article
|
| 50 |
Estimation of mutation frequencies in normal mammalian cells and the development of cancer
|
Turker, Mitchell S.
|
|
1998
|
104-105 |
6 |
p. 407-419
13 p.
|
article
|
| 51 |
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells
|
Speiser, Daniel E.
|
|
2003
|
104-105 |
6 |
p. 461-472
12 p.
|
article
|
| 52 |
Evolution and the inevitability of human cancer
|
Simpson, Andrew J.G.
|
|
1998
|
104-105 |
6 |
p. 439-445
7 p.
|
article
|
| 53 |
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses
|
Rouas-Freiss, Nathalie
|
|
2007
|
104-105 |
6 |
p. 413-421
9 p.
|
article
|
| 54 |
Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer
|
Nakamura, Hajime
|
|
2006
|
104-105 |
6 |
p. 444-451
8 p.
|
article
|
| 55 |
Failsafe program escape and EMT: A deleterious partnership
|
Ansieau, Stéphane
|
|
2011
|
104-105 |
6 |
p. 392-396
5 p.
|
article
|
| 56 |
Familial nasopharyngeal carcinoma
|
Zeng, Yi-Xin
|
|
2002
|
104-105 |
6 |
p. 443-450
8 p.
|
article
|
| 57 |
Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects
|
Prendergast, George C
|
|
2000
|
104-105 |
6 |
p. 443-452
10 p.
|
article
|
| 58 |
Genetic alterations and DNA repair in human carcinogenesis
|
Dixon, Kathleen
|
|
2004
|
104-105 |
6 |
p. 441-448
8 p.
|
article
|
| 59 |
Genetic and epigenetic changes in nasopharyngeal carcinoma
|
Lo, Kwok-Wai
|
|
2002
|
104-105 |
6 |
p. 451-462
12 p.
|
article
|
| 60 |
Genetic instability in cancer: Theory and experiment
|
Beckman, Robert A.
|
|
2005
|
104-105 |
6 |
p. 423-435
13 p.
|
article
|
| 61 |
Genetic variation and risk of chronic lymphocytic leukaemia
|
Crowther-Swanepoel, Dalemari
|
|
2010
|
104-105 |
6 |
p. 363-369
7 p.
|
article
|
| 62 |
Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors
|
Blachere, Nathalie E.
|
|
1995
|
104-105 |
6 |
p. 349-355
7 p.
|
article
|
| 63 |
Heterogeneity of papillomaviruses
|
Myers, Gerald
|
|
1996
|
104-105 |
6 |
p. 349-358
10 p.
|
article
|
| 64 |
HLA control in the progression of human papillomavirus infections
|
Breitburd, Françoise
|
|
1996
|
104-105 |
6 |
p. 359-371
13 p.
|
article
|
| 65 |
HLA-G and cancer
|
Carosella, Edgardo D.
|
|
2007
|
104-105 |
6 |
p. 411-412
2 p.
|
article
|
| 66 |
HLA-G expression in malignant melanoma
|
Rebmann, Vera
|
|
2007
|
104-105 |
6 |
p. 422-429
8 p.
|
article
|
| 67 |
HLA-G in B-chronic lymphocytic leukaemia: Clinical relevance and functional implications
|
Rebmann, Vera
|
|
2007
|
104-105 |
6 |
p. 430-435
6 p.
|
article
|
| 68 |
HLA-G in the skin—Friend or foe?
|
Urosevic, Mirjana
|
|
2007
|
104-105 |
6 |
p. 480-484
5 p.
|
article
|
| 69 |
How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
|
Allday, Martin J.
|
|
2009
|
104-105 |
6 |
p. 366-376
11 p.
|
article
|
| 70 |
Human papillomaviruses in non-melanoma skin cancer
|
de Villiers, Ethel-Michele
|
|
1999
|
104-105 |
6 |
p. 413-422
10 p.
|
article
|
| 71 |
Human papillomavirus life cycle: active and latent phases
|
Stubenrauch, Frank
|
|
1999
|
104-105 |
6 |
p. 379-386
8 p.
|
article
|
| 72 |
Human papillomavirus vaccines
|
Breitburd, Françoise
|
|
1999
|
104-105 |
6 |
p. 431-445
15 p.
|
article
|
| 73 |
Hypermutability and silent mutations in human carcinogenesis
|
Strauss, Bernard S.
|
|
1998
|
104-105 |
6 |
p. 431-438
8 p.
|
article
|
| 74 |
Identification of EBV transforming genes by recombinant EBV technology
|
Izumi, Kenneth M.
|
|
2001
|
104-105 |
6 |
p. 407-414
8 p.
|
article
|
| 75 |
Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
|
zur Hausen, Harald
|
|
1999
|
104-105 |
6 |
p. 405-411
7 p.
|
article
|
| 76 |
Immune escape by Epstein–Barr virus associated malignancies
|
Münz, Christian
|
|
2008
|
104-105 |
6 |
p. 381-387
7 p.
|
article
|
| 77 |
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis
|
Liang, Chengyu
|
|
2008
|
104-105 |
6 |
p. 423-436
14 p.
|
article
|
| 78 |
Immune-refractory cancers and their little helpers—An extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
|
Wischhusen, Jörg
|
|
2007
|
104-105 |
6 |
p. 459-468
10 p.
|
article
|
| 79 |
Immunotherapy of melanoma
|
Parmiani, Giorgio
|
|
2003
|
104-105 |
6 |
p. 391-400
10 p.
|
article
|
| 80 |
Immunotherapy of melanoma: the good news, the bad ones and what to do next
|
Marincola, Francesco M.
|
|
2003
|
104-105 |
6 |
p. 387-389
3 p.
|
article
|
| 81 |
Infectious agents and cancer: criteria for a causal relation
|
Pagano, Joseph S.
|
|
2004
|
104-105 |
6 |
p. 453-471
19 p.
|
article
|
| 82 |
Inflammation as a tumor promoter in cancer induction
|
Philip, Mary
|
|
2004
|
104-105 |
6 |
p. 433-439
7 p.
|
article
|
| 83 |
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015
|
McCormick, Frank
|
|
2000
|
104-105 |
6 |
p. 453-459
7 p.
|
article
|
| 84 |
Interactions of the human papillomavirus E7 protein with cell cycle regulators
|
Jones, D.Leanne
|
|
1996
|
104-105 |
6 |
p. 327-337
11 p.
|
article
|
| 85 |
Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation
|
Zhang, Luwen
|
|
2001
|
104-105 |
6 |
p. 445-453
9 p.
|
article
|
| 86 |
Introduction
|
Simpson, Andrew J.G.
|
|
1998
|
104-105 |
6 |
p. 403-405
3 p.
|
article
|
| 87 |
Introduction
|
de Villiers, Ethel-Michele
|
|
1999
|
104-105 |
6 |
p. 377-
1 p.
|
article
|
| 88 |
Introduction: Cancer vaccines
|
Livingston, Philip O.
|
|
1995
|
104-105 |
6 |
p. 319-320
2 p.
|
article
|
| 89 |
Introduction: Human papillomavirus
|
Thierry, Françoise
|
|
1996
|
104-105 |
6 |
p. 307-
1 p.
|
article
|
| 90 |
Introduction: nasopharyngeal cancer
|
Huang, Dolly P
|
|
2002
|
104-105 |
6 |
p. 419-
1 p.
|
article
|
| 91 |
LMP1 structure and signal transduction
|
Eliopoulos, Aristides G
|
|
2001
|
104-105 |
6 |
p. 435-444
10 p.
|
article
|
| 92 |
Local delivery of poxvirus vaccines for melanoma
|
Hörig, Heidi
|
|
2003
|
104-105 |
6 |
p. 417-422
6 p.
|
article
|
| 93 |
Manipulation of the immune response by Epstein–Barr virus and Kaposi's sarcoma-associated herpesvirus: Consequences for tumor development
|
Ressing, Maaike E.
|
|
2008
|
104-105 |
6 |
p. 379-380
2 p.
|
article
|
| 94 |
Matrix metalloproteinases in tumor invasion and metastasis
|
Stamenkovic, Ivan
|
|
2000
|
104-105 |
6 |
p. 415-433
19 p.
|
article
|
| 95 |
Mechanism of HPV E6 proteins in cellular transformation
|
Huibregtse, Jon M.
|
|
1996
|
104-105 |
6 |
p. 317-326
10 p.
|
article
|
| 96 |
MicroRNAs of Kaposi's sarcoma-associated herpes virus
|
Ganem, Don
|
|
2008
|
104-105 |
6 |
p. 437-440
4 p.
|
article
|
| 97 |
Modern criteria to determine the etiology of human carcinogens
|
Mossman, Brooke T.
|
|
2004
|
104-105 |
6 |
p. 449-452
4 p.
|
article
|
| 98 |
Modern criteria to establish human cancer etiology
|
Carbone, Michele
|
|
2004
|
104-105 |
6 |
p. 397-398
2 p.
|
article
|
| 99 |
Molecular basis of CLL
|
Pekarsky, Yuri
|
|
2010
|
104-105 |
6 |
p. 370-376
7 p.
|
article
|
| 100 |
Motexafin gadolinium: A novel redox active drug for cancer therapy
|
Magda, Darren
|
|
2006
|
104-105 |
6 |
p. 466-476
11 p.
|
article
|
| 101 |
Multiple roles of LMP1 in Epstein-Barr virus induced immune escape
|
Middeldorp, J.M.
|
|
2008
|
104-105 |
6 |
p. 388-396
9 p.
|
article
|
| 102 |
Multistep and multifactorial carcinogenesis: when does a contributing factor become a carcinogen?
|
Carbone, Michele
|
|
2004
|
104-105 |
6 |
p. 399-405
7 p.
|
article
|
| 103 |
Multistep skin cancer in mice as a model to study the evolution of cancer cells
|
Kemp, Christopher J.
|
|
2005
|
104-105 |
6 |
p. 460-473
14 p.
|
article
|
| 104 |
Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy
|
Lee, Steven P
|
|
2002
|
104-105 |
6 |
p. 463-471
9 p.
|
article
|
| 105 |
Natural selection in neoplastic progression of Barrett's esophagus
|
Maley, Carlo C.
|
|
2005
|
104-105 |
6 |
p. 474-483
10 p.
|
article
|
| 106 |
New aspects of integrin signaling in cancer
|
Parise, Leslie V
|
|
2000
|
104-105 |
6 |
p. 407-414
8 p.
|
article
|
| 107 |
New insights into the pathogenesis of chronic lymphocytic leukemia
|
Klein, Ulf
|
|
2010
|
104-105 |
6 |
p. 377-383
7 p.
|
article
|
| 108 |
[No title]
|
Wodarz, D.
|
|
2005
|
104-105 |
6 |
p. 421-422
2 p.
|
article
|
| 109 |
Novel gene therapy approach for nasopharyngeal carcinoma
|
Liu, Fei-Fei
|
|
2002
|
104-105 |
6 |
p. 505-515
11 p.
|
article
|
| 110 |
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
|
Larsson, Lars-Gunnar
|
|
2011
|
104-105 |
6 |
p. 367-376
10 p.
|
article
|
| 111 |
On the origin of multiple mutations in human cancers
|
Jackson, Aimee L.
|
|
1998
|
104-105 |
6 |
p. 421-429
9 p.
|
article
|
| 112 |
On the potential of thioredoxin reductase inhibitors for cancer therapy
|
Urig, Sabine
|
|
2006
|
104-105 |
6 |
p. 452-465
14 p.
|
article
|
| 113 |
Papillomaviruses in non-melanoma skin cancer: epidemiological aspects
|
Kiviat, Nancy B.
|
|
1999
|
104-105 |
6 |
p. 397-403
7 p.
|
article
|
| 114 |
Papillomavirus-like particles and HPV vaccine development
|
Schiller, John T.
|
|
1996
|
104-105 |
6 |
p. 373-382
10 p.
|
article
|
| 115 |
Peptide vaccine trials for melanoma: preclinical background and clinical results
|
Talebi, Tony
|
|
2003
|
104-105 |
6 |
p. 431-438
8 p.
|
article
|
| 116 |
Proof for EBV's sustaining role in Burkitt's lymphomas
|
Vereide, David
|
|
2009
|
104-105 |
6 |
p. 389-393
5 p.
|
article
|
| 117 |
Rational peptide-based tumour vaccine development and T cell monitoring
|
Scheibenbogen, Carmen
|
|
2003
|
104-105 |
6 |
p. 423-429
7 p.
|
article
|
| 118 |
Restricted expression of EBV encoded proteins in in vitro infected CLL cells
|
Klein, Eva
|
|
2010
|
104-105 |
6 |
p. 410-415
6 p.
|
article
|
| 119 |
Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
|
Sondak, Vernon K
|
|
2003
|
104-105 |
6 |
p. 409-415
7 p.
|
article
|
| 120 |
Role and limitations of epidemiology in establishing a causal association
|
Franco, Eduardo L.
|
|
2004
|
104-105 |
6 |
p. 413-426
14 p.
|
article
|
| 121 |
Role of EBV in microRNA dysregulation in Burkitt lymphoma
|
De Falco, Giulia
|
|
2009
|
104-105 |
6 |
p. 401-406
6 p.
|
article
|
| 122 |
Role of LMP1 in immune control of EBV infection
|
Pai, Saparna
|
|
2001
|
104-105 |
6 |
p. 455-460
6 p.
|
article
|
| 123 |
Role of telomeres and telomerase in cancer
|
Shay, Jerry W.
|
|
2011
|
104-105 |
6 |
p. 349-353
5 p.
|
article
|
| 124 |
Selection of potent immunological adjuvants for vaccine construction
|
McElrath, Margaret Juliana
|
|
1995
|
104-105 |
6 |
p. 375-385
11 p.
|
article
|
| 125 |
Selective evolutionary pressure from the tissue microenvironment drives tumor progression
|
Smalley, Keiran S.M.
|
|
2005
|
104-105 |
6 |
p. 451-459
9 p.
|
article
|
| 126 |
Senescence and pre-malignancy: How do tumors progress?
|
Saab, Raya
|
|
2011
|
104-105 |
6 |
p. 385-391
7 p.
|
article
|
| 127 |
Signalling events regulating lymphoid growth and survival
|
Brennan, Paul
|
|
2001
|
104-105 |
6 |
p. 415-421
7 p.
|
article
|
| 128 |
Soluble HLA-G: Are they clinically relevant?
|
Pistoia, Vito
|
|
2007
|
104-105 |
6 |
p. 469-479
11 p.
|
article
|
| 129 |
Somatic evolution of cancer cells
|
Boland, C. Richard
|
|
2005
|
104-105 |
6 |
p. 436-450
15 p.
|
article
|
| 130 |
Structure, expression and function of HLA-G in renal cell carcinoma
|
Seliger, Barbara
|
|
2007
|
104-105 |
6 |
p. 444-450
7 p.
|
article
|
| 131 |
Subject index 1995
|
|
|
1995
|
104-105 |
6 |
p. III-VIII
nvt p.
|
article
|
| 132 |
Targeting tumor vasculature with homing peptides from phage display
|
Ruoslahti, Erkki
|
|
2000
|
104-105 |
6 |
p. 435-442
8 p.
|
article
|
| 133 |
T-cell function in chronic lymphocytic leukaemia
|
Riches, John C.
|
|
2010
|
104-105 |
6 |
p. 431-438
8 p.
|
article
|
| 134 |
Telomerase and human tumorigenesis
|
Stewart, Sheila A.
|
|
2000
|
104-105 |
6 |
p. 399-406
8 p.
|
article
|
| 135 |
The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia
|
Galloway, Denise A.
|
|
1996
|
104-105 |
6 |
p. 309-315
7 p.
|
article
|
| 136 |
The epigenetics of cancer etiology
|
Feinberg, Andrew P.
|
|
2004
|
104-105 |
6 |
p. 427-432
6 p.
|
article
|
| 137 |
The interaction between p53 and papillomaviruses
|
Mantovani, Fiamma
|
|
1999
|
104-105 |
6 |
p. 387-395
9 p.
|
article
|
| 138 |
The Myc/macrophage tango: Oncogene-induced senescence, Myc style
|
Lee, Soyoung
|
|
2011
|
104-105 |
6 |
p. 377-384
8 p.
|
article
|
| 139 |
The next wave of recombinant and synthetic anticancer vaccines
|
Irvine, Kari R.
|
|
1995
|
104-105 |
6 |
p. 337-347
11 p.
|
article
|
| 140 |
The role of EBERs in oncogenesis
|
Takada, Kenzo
|
|
2001
|
104-105 |
6 |
p. 461-467
7 p.
|
article
|
| 141 |
The role of HLA-G in gastrointestinal inflammatory disease and malignancy
|
Downs-Kelly, Erinn
|
|
2007
|
104-105 |
6 |
p. 451-458
8 p.
|
article
|
| 142 |
The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia
|
Packham, Graham
|
|
2010
|
104-105 |
6 |
p. 391-399
9 p.
|
article
|
| 143 |
The serological response to papillomaviruses
|
Dillner, Joakim
|
|
1999
|
104-105 |
6 |
p. 423-430
8 p.
|
article
|
| 144 |
The significance of LMP1 expression in nasopharyngeal carcinoma
|
Tsao, Sai Wah
|
|
2002
|
104-105 |
6 |
p. 473-487
15 p.
|
article
|
| 145 |
The thioredoxin system in cancer
|
Arnér, Elias S.J.
|
|
2006
|
104-105 |
6 |
p. 420-426
7 p.
|
article
|
| 146 |
The thioredoxin system in cancer—introduction to a thematic volume of Seminars in Cancer Biology
|
Arnér, Elias S.J.
|
|
2006
|
104-105 |
6 |
p. 419-
1 p.
|
article
|
| 147 |
The use of genetic instability as a clinical tool for cancer diagnosis
|
Bevilacqua, Roberta A.U.
|
|
1998
|
104-105 |
6 |
p. 447-453
7 p.
|
article
|
| 148 |
Thioredoxin and protein kinases in redox signaling
|
Fujino, Go
|
|
2006
|
104-105 |
6 |
p. 427-435
9 p.
|
article
|
| 149 |
Thioredoxin in cancer—Role of histone deacetylase inhibitors
|
Marks, Paul A.
|
|
2006
|
104-105 |
6 |
p. 436-443
8 p.
|
article
|
| 150 |
To the genesis of Burkitt lymphoma: Regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes
|
Nagy, Noemi
|
|
2009
|
104-105 |
6 |
p. 407-410
4 p.
|
article
|
| 151 |
Treatment strategy and clinical experience
|
Teo, Peter M.L
|
|
2002
|
104-105 |
6 |
p. 497-504
8 p.
|
article
|
| 152 |
Viral and cellular MARCH ubiquitin ligases and cancer
|
Wang, Xiaoli
|
|
2008
|
104-105 |
6 |
p. 441-450
10 p.
|
article
|
| 153 |
Volume and contents of volume 8, 1998
|
|
|
1998
|
104-105 |
6 |
p. i-xv
nvt p.
|
article
|
| 154 |
Volume Contents and Index
|
|
|
1999
|
104-105 |
6 |
p. i-xii
nvt p.
|
article
|
| 155 |
Volume contents, Auhtor and Keywords
|
|
|
2002
|
104-105 |
6 |
p. I-X
nvt p.
|
article
|
| 156 |
Volume Contents, Author and Keyword Indexes
|
|
|
2003
|
104-105 |
6 |
p. I-XI
nvt p.
|
article
|
| 157 |
Where is the biology of CLL leading us?
|
Caligaris-Cappio, Federico
|
|
2010
|
104-105 |
6 |
p. 361-362
2 p.
|
article
|
Journal description